Skip to main content
Equibles
CARL logo

CARL · Carlsmed, Inc. · Webcasts, Transcripts & Audio

Track CARL — free

Use CARL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CARL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.99 -0.79 (-4.98%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$430.56M
Shares
27.30M
Volume · Oct 30 42.27K Avg daily vol (3M) 111.94K

Carlsmed, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Carlsmed, Inc. (CARL), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Conference
Investor event
2026-08-12
Carlsmed, Inc. (CARL) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript
Confident tone Prevo Cervical and Quora Launch Revenue Growth and Guidance Raise Lumbar Franchise Expansion (Bilateral)
Revenue
$18.94M
▲ 56.7% YoY
Diluted EPS
$-0.39
Gross margin
76.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-16
Carlsmed, Inc. (CARL) June 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-12
Carlsmed, Inc. (CARL) May 12, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript
Confident tone Aprivo platform and product portfolio Revenue growth and Q1 results Cervical expansion
Revenue
$16.12M
▲ 58.2% YoY
Diluted EPS
$-0.32
Gross margin
77.1%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript
Confident tone Patient-Centric Innovation and Product Launches 2026 Guidance and Cautious Outlook Cervical Market Expansion
Revenue
$15.16M*
Gross margin
76.5%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Carlsmed, Inc. (CARL) Q3 2025 Earnings Call
Revenue
$13.07M
▲ 98.4% YoY
Diluted EPS
$-0.40
Gross margin
75.9%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-28
Carlsmed, Inc. (CARL) Q2 2025 Earnings Call
Revenue
$12.08M
▲ 98.7% YoY
Diluted EPS
$-1.47
Gross margin
73.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 webcasts
Key facts CIK 1794546 CUSIP 14280C105 13F (30d) 13 filings 13 filers Visit website Investor relations